Eli Lilly's obesity drug Mounjaro's India sales hit a sweet spot within six months of launch

 Eli Lilly's breakthrough weight-loss and diabetes drug Mounjaro has stunned the Indian pharmaceutical market, rising to the no. 2 position in sales within six months of its launch - a feat rarely seen in recent pharma history.

Read full story. Click here